Navigation Links
What are the risk factors for rebleeding after negative angiography?
Date:9/16/2009

Acute non-variceal gastrointestinal bleeding accounts for approximately 20% of emergency room visits and 5% of admissions. Although endoscopy has been used as a first-line treatment option in patients with gastrointestinal bleeding, angiographic intervention can be used as a safe diagnostic and treatment method in patients with gastrointestinal bleeding that is refractory to endoscopic treatment. The incidence of rebleeding in patients with negative initial angiography has been reported in up to 60% of cases. However, little is known about the predictive factors for rebleeding.

A research article to be published on August 28, 2009 in the World Journal of Gastroenterology addresses this question. A research team led by Hyo-Cheol Kim from Seoul National University Hospital, Korea, identified the possible predictive factors for rebleeding after negative angiographic findings in patients with acute non-variceal gastrointestinal bleeding.

One hundred and twenty eight patients with acute non-variceal gastrointestinal bleeding had negative findings after initial angiography. Clinical and laboratory parameters were analyzed retrospectively.

They found that clinical factors including underlying malignancy, liver cirrhosis, and hematemesis are important predictors for rebleeding after angiographically negative findings in patients with acute non-variceal gastrointestinal bleeding.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Study, meta-analysis examine factors associated with death from heatstroke
3. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
4. Severe heart defect likely caused by genetic factors
5. Aggressively Treating Cardiac Risk Factors May Reverse Ischemia
6. Largest Study Ever to Investigate Risk Factors of Autism and Other Developmental Disabilities Will Begin Enrolling Families in Bay Area and Across U.S.
7. Age, burden, divorce and heavy tea consumption are significant risk factors for erosive esophagitis
8. Cell Addiction to Growth Factors May Help Spur Cancers
9. Study examines factors associated with survival in advanced laryngeal cancer
10. Cardiovascular disease death rates decline, but risk factors still exact heavy toll
11. Human factors researchers test voting systems for seniors that can improve voting accuracy and speed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital is ... Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital within ... nation. While many providers are struggling to leverage limited resources and technology, Onslow Memorial ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... and financial planning assistance to families and business owners in the greater Fort ... 4 Families organization. , For more than 30 years, LifeNet 4 Families ...
(Date:2/16/2017)... ... 2017 , ... Teaching nursing care of vulnerable children is the focus of ... being created with the support of the Hearst Foundations. An initiative of the ... what has been identified as a critical gap in preparing the next generation of ...
(Date:2/16/2017)... Lancaster, CA (PRWEB) , ... February 16, 2017 ... ... addition of the highly regarded orthopedic surgeon, Dr. Raj, to their network through ... undergraduate degree in Chemistry from Dalhousie University, and his medical degree from Canada’s ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... -- Perrigo Company plc (NYSE, TASE: PRGO) today announced it has ... for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 ... and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per ... in adults and children 6 years of age and older. ... approximately $16 million.   ...
(Date:2/17/2017)... , Feb 17, 2017 Research and Markets ... Business Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Latin America ... the period 2015 through 2022. Also, a six-year historic analysis is provided ...
(Date:2/17/2017)... partnership with CitiHope , Panexus Haiti ... Jack Brewer Foundation (JBF Worldwide) has sent a ... medicine to Innovating Health International (IHI) in ... to treating chronic diseases and addressing women,s health issues in developing ... and providing these medicines to the organization ...
Breaking Medicine Technology: